WO2001091773A3 - Method of stimulating hair growth - Google Patents

Method of stimulating hair growth Download PDF

Info

Publication number
WO2001091773A3
WO2001091773A3 PCT/US2001/017386 US0117386W WO0191773A3 WO 2001091773 A3 WO2001091773 A3 WO 2001091773A3 US 0117386 W US0117386 W US 0117386W WO 0191773 A3 WO0191773 A3 WO 0191773A3
Authority
WO
WIPO (PCT)
Prior art keywords
hair growth
matrix
stimulating hair
oxide inhibitors
intradermal
Prior art date
Application number
PCT/US2001/017386
Other languages
French (fr)
Other versions
WO2001091773A2 (en
Inventor
Anton-Lewis Usala
Original Assignee
Encelle Inc
Usala Anton Lewis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Encelle Inc, Usala Anton Lewis filed Critical Encelle Inc
Priority to CA2410965A priority Critical patent/CA2410965C/en
Priority to AU2001265151A priority patent/AU2001265151A1/en
Publication of WO2001091773A2 publication Critical patent/WO2001091773A2/en
Publication of WO2001091773A3 publication Critical patent/WO2001091773A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/042Gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • A61K38/012Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/014Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052Mixtures of macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061Use of materials characterised by their function or physical properties
    • A61L26/008Hydrogels or hydrocolloids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52Hydrogels or hydrocolloids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/18Materials or treatment for tissue regeneration for hair reconstruction

Abstract

The invention provides a method of stimulating hair growth, comprising administering a therapeutic amount of a hydrogel matrix to an intradermal or subdermal site where hair growth is desired, the matrix composition comprising gelatin, such as denatured collagen, and a long chain carbohydrate, such as dextran. The matrix may further include polar amino acids, nitric oxide inhibitors and super oxide inhibitors. Injection is a preferred method of administration.
PCT/US2001/017386 2000-05-31 2001-05-30 Method of stimulating hair growth WO2001091773A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA2410965A CA2410965C (en) 2000-05-31 2001-05-30 Method of stimulating hair growth
AU2001265151A AU2001265151A1 (en) 2000-05-31 2001-05-30 Method of stimulating hair growth

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20811600P 2000-05-31 2000-05-31
US60/208,116 2000-05-31

Publications (2)

Publication Number Publication Date
WO2001091773A2 WO2001091773A2 (en) 2001-12-06
WO2001091773A3 true WO2001091773A3 (en) 2002-05-02

Family

ID=22773242

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2001/017387 WO2001091774A2 (en) 2000-05-31 2001-05-30 Method of treating chronic ulcers
PCT/US2001/017386 WO2001091773A2 (en) 2000-05-31 2001-05-30 Method of stimulating hair growth

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/US2001/017387 WO2001091774A2 (en) 2000-05-31 2001-05-30 Method of treating chronic ulcers

Country Status (8)

Country Link
US (2) US7700660B2 (en)
EP (1) EP1289537B1 (en)
AT (1) ATE311192T1 (en)
AU (3) AU2001265151A1 (en)
CA (2) CA2410965C (en)
DE (1) DE60115433T2 (en)
NZ (1) NZ523461A (en)
WO (2) WO2001091774A2 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7828749B2 (en) * 1996-05-17 2010-11-09 Roche Diagnostics Operations, Inc. Blood and interstitial fluid sampling device
EP1610674A4 (en) * 2003-03-13 2008-05-21 Cheryl M Burgess Methods of administering a material into a patient for dermal enhancement
JP2005269232A (en) * 2004-03-18 2005-09-29 Renesas Technology Corp Frequency mixer
EP1755579A4 (en) * 2004-05-24 2009-06-10 Univ New York Method of treating or preventing pathologic effects of acute increases in hyperglycemia and/or acute increases of free fatty acid flux
WO2009137074A1 (en) * 2008-05-06 2009-11-12 Indigene Pharmaceuticals, Inc. Compositions and methods for treating diabetic ulcers
US10098857B2 (en) 2008-10-10 2018-10-16 The Board Of Trustees Of The Leland Stanford Junior University Topical and transdermal delivery of HIF-1 modulators to prevent and treat chronic wounds
EP2236617A1 (en) * 2009-03-31 2010-10-06 Leukocare Ag Methods of terminal sterilization of biofunctional compositions
AU2010314994B2 (en) 2009-11-09 2016-10-06 Spotlight Technology Partners Llc Fragmented hydrogels
EP2498763A4 (en) 2009-11-09 2015-10-07 Spotlight Technology Partners Llc Polysaccharide based hydrogels
CA2854160A1 (en) 2011-11-02 2013-05-10 Halscion, Inc. Methods and compositions for wound treatment
EP2793963B1 (en) 2011-12-23 2015-11-18 Pioneer Surgical Technology, Inc. Continuous matrix with osteoconductive particles dispersed therein, method of forming thereof, and method of regenerating bone therewith
WO2017069113A1 (en) * 2015-10-20 2017-04-27 国立大学法人 東京医科歯科大学 Hair-growth promoting composition and usage thereof
KR102085404B1 (en) * 2016-08-31 2020-03-05 주식회사 에스엔비아 Composition for treatment of partial obesity and microneedle comprising the composition
CN110121330B (en) 2016-12-21 2022-04-29 联合利华知识产权控股有限公司 Personal care compositions with glutathione precursors comprising 4-substituted resorcinols and amino acids
CN114767562A (en) 2016-12-21 2022-07-22 联合利华知识产权控股有限公司 Topical skin lightening additives and compositions with amino acid and nicotinamide compounds
JP7082623B2 (en) 2016-12-21 2022-06-08 ユニリーバー・アイピー・ホールディングス・ベスローテン・ヴェンノーツハップ Composition for personal care with cystine
US10751267B2 (en) 2016-12-21 2020-08-25 Conopco, Inc. Personal care compositions comprising poorly soluble compounds
US11331288B2 (en) 2017-09-14 2022-05-17 The Board Of Trustees Of The Leland Stanford Junior University Conditioning irradiated tissue for increasing vascularity
MX2020012410A (en) 2018-05-23 2022-03-29 Unilever Ip Holdings B V Nanoemulsions and a method for making the same.
CN113679846B (en) * 2021-08-31 2023-05-09 佛山市第一人民医院(中山大学附属佛山医院) Hair regenerating agent and preparation method and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993016717A1 (en) * 1992-02-25 1993-09-02 The Rockefeller University Method and agents for promoting wound healing
WO2000002596A1 (en) * 1998-07-10 2000-01-20 Encelle, Inc. Methods for increasing vascularization and promoting wound healing

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4198479A (en) * 1979-03-30 1980-04-15 Merck & Co., Inc. Replacement of animal serum proteins by human albumin for growth and interferon production by Namalva cells
US4520821A (en) 1982-04-30 1985-06-04 The Regents Of The University Of California Growing of long-term biological tissue correction structures in vivo
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US5852009A (en) 1984-03-19 1998-12-22 The Rockefeller University Compositions, including pharmaceutical compositions, for inhibiting the advanced glycosylation of proteins, and therapeutic methods based thereon
US4665192A (en) * 1984-03-19 1987-05-12 The Rockefeller University 2-(2-furoyl)-4(5)-2(furanyl)-1H-imidazole
US4868121A (en) * 1985-02-07 1989-09-19 Mcdonnell Douglas Corporation Islet isolation process
NO166836C (en) 1985-03-14 1991-09-11 Univ California PROCEDURE FOR TREATMENT OF AN ORGAN TRANSPLANT.
US4902295A (en) 1985-08-26 1990-02-20 Hana Biologics, Inc. Transplantable artificial tissue
AU589438B2 (en) 1985-08-26 1989-10-12 Hana Biologics, Inc. Transplantable artificial tissue and process
GB8604497D0 (en) * 1986-02-24 1986-04-03 Connaught Lab Separation of islets of langerhans
FR2600076A1 (en) * 1986-06-12 1987-12-18 Fond Ctre Nal Transfusion CULTURE MEDIUM COMPRISING HUMAN ALBUMIN, PROCESS FOR PREPARING A PRODUCT INJECTABLE THEREFROM, PRODUCT OBTAINED AND USE THEREOF, COMPOSITION OBTAINED
US5079160A (en) * 1987-06-08 1992-01-07 Lacy Paul E Method to isolate clusters of cell subtypes from organs
US5457093A (en) * 1987-09-18 1995-10-10 Ethicon, Inc. Gel formulations containing growth factors
AU632273B2 (en) 1988-03-09 1992-12-24 Terumo Kabushiki Kaisha Medical material permitting cells to enter thereinto and artificial skin
US4950483A (en) * 1988-06-30 1990-08-21 Collagen Corporation Collagen wound healing matrices and process for their production
EP0363125A3 (en) 1988-10-03 1990-08-16 Hana Biologics Inc. Proliferated pancreatic endocrine cell product and process
US4957902A (en) * 1988-12-20 1990-09-18 Board Of Regents, The University Of Texas System Peptide inhibitors of wound contraction
US5059588A (en) * 1989-10-13 1991-10-22 Procyte Corporation, Incorporated Methods and compositions for healing bone using gly his lys: copper
WO1991009119A1 (en) 1989-12-13 1991-06-27 Trancel Corporation Improved alginate microcapsules, methods of making and using same
US5645591A (en) 1990-05-29 1997-07-08 Stryker Corporation Synthetic bone matrix
US5336616A (en) 1990-09-12 1994-08-09 Lifecell Corporation Method for processing and preserving collagen-based tissues for transplantation
US5192312A (en) * 1991-03-05 1993-03-09 Colorado State University Research Foundation Treated tissue for implantation and methods of treatment and use
DK0585368T3 (en) 1991-04-25 1998-03-16 Univ Brown Res Found Implantable biocompatible immuno-insulating vehicle for delivery of selected therapeutic products
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
CA2071137A1 (en) 1991-07-10 1993-01-11 Clarence C. Lee Composition and method for revitalizing scar tissue
US5591709A (en) 1991-08-30 1997-01-07 Life Medical Sciences, Inc. Compositions and methods for treating wounds
WO1994015589A1 (en) 1992-12-30 1994-07-21 Clover Consolidated, Limited Cytoprotective, biocompatible, retrievable macrocapsule containment systems for biologically active materials
US5358969A (en) * 1991-12-16 1994-10-25 Washington University Method of inhibiting nitric oxide formation
US5246971A (en) 1991-12-16 1993-09-21 Washington University Method of inhibiting nitric oxide formation
US5824331A (en) * 1992-02-24 1998-10-20 Encelle, Inc. Bioartificial devices and cellular matrices therefor
US5834005A (en) * 1992-02-24 1998-11-10 Encelle, Inc. Bioartificial devices and cellular matrices therefor
EP0587840B1 (en) 1992-02-24 1999-12-15 Encelle, Inc. Bioartificial endocrine device
US6231881B1 (en) 1992-02-24 2001-05-15 Anton-Lewis Usala Medium and matrix for long-term proliferation of cells
US5830492A (en) 1992-02-24 1998-11-03 Encelle, Inc. Bioartificial devices and cellular matrices therefor
AU4397593A (en) 1992-05-29 1993-12-30 Vivorx, Inc. Microencapsulation of cells
JPH08500033A (en) 1992-07-29 1996-01-09 ワシントン・ユニバーシティ Use of pouch for live cell transplant
US5262055A (en) 1992-10-19 1993-11-16 The University Of Utah Implantable and refillable biohybrid artificial pancreas
DE4431598C2 (en) 1993-03-03 1997-03-20 Michael Sittinger Process for producing an implant from cell cultures
WO1995014037A1 (en) 1993-11-17 1995-05-26 Ibah, Inc. Transparent liquid for encapsulated drug delivery
NZ278809A (en) 1994-01-13 1998-03-25 Rogosin Inst Macroencapsulation of secretory cells in an agarose collagen gel material coated with agarose
US5487899A (en) * 1994-01-31 1996-01-30 Jess Clarke & Sons, Inc. Wound healing
US5716404A (en) * 1994-12-16 1998-02-10 Massachusetts Institute Of Technology Breast tissue engineering
US5840059A (en) 1995-06-07 1998-11-24 Cardiogenesis Corporation Therapeutic and diagnostic agent delivery
CA2179341A1 (en) 1996-04-12 1997-10-13 Gregory S. Korbutt Methods for isolating, enriching and increasing the maturation of cells
EP0914168A1 (en) 1996-05-03 1999-05-12 Innogenetics N.V. New medicaments containing gelatin cross-linked with oxidized polysaccharides
US5972332A (en) * 1997-04-16 1999-10-26 The Regents Of The University Of Michigan Wound treatment with keratinocytes on a solid support enclosed in a porous material
JP3602145B2 (en) 1997-06-03 2004-12-15 イノジェネティックス・ナムローゼ・フェンノートシャップ New pharmaceuticals based on polymers composed of methacrylamide-modified gelatin
EP1041996A4 (en) * 1997-12-22 2003-05-14 Human Genome Sciences Inc Keratinocyte growth factor-2 formulations
US6372494B1 (en) * 1999-05-14 2002-04-16 Advanced Tissue Sciences, Inc. Methods of making conditioned cell culture medium compositions
US6046160A (en) * 1999-07-22 2000-04-04 Deroyal Industries, Inc. Composition and method for enhancing wound healing
US6491953B1 (en) * 2000-01-07 2002-12-10 Amcol International Corporation Controlled release compositions and method
US20020146439A1 (en) * 2000-03-31 2002-10-10 Delong Mitchell Anthony Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993016717A1 (en) * 1992-02-25 1993-09-02 The Rockefeller University Method and agents for promoting wound healing
WO2000002596A1 (en) * 1998-07-10 2000-01-20 Encelle, Inc. Methods for increasing vascularization and promoting wound healing

Also Published As

Publication number Publication date
WO2001091774A3 (en) 2002-05-02
NZ523461A (en) 2004-11-26
EP1289537A2 (en) 2003-03-12
US20020077277A1 (en) 2002-06-20
ATE311192T1 (en) 2005-12-15
US20020065222A1 (en) 2002-05-30
US6992062B2 (en) 2006-01-31
CA2410968C (en) 2011-03-29
CA2410965A1 (en) 2001-12-06
US7700660B2 (en) 2010-04-20
DE60115433D1 (en) 2006-01-05
WO2001091774A2 (en) 2001-12-06
AU2001263495B2 (en) 2005-06-02
CA2410965C (en) 2010-09-14
AU2001265151A1 (en) 2001-12-11
CA2410968A1 (en) 2001-12-06
WO2001091773A2 (en) 2001-12-06
AU6349501A (en) 2001-12-11
EP1289537B1 (en) 2005-11-30
DE60115433T2 (en) 2006-08-03

Similar Documents

Publication Publication Date Title
WO2001091773A3 (en) Method of stimulating hair growth
WO2003017826A3 (en) Processed soft tissue for topical or internal application
HUP9904023A2 (en) Use of leptin antagonists for treating insulin resistance in type ii diabetes
EP2158907A3 (en) Topical administration of arginine for pain treatment
DE60111068D1 (en) POLYMIC ADMINISTRATION OF LEUPROLIDE WITH IMPROVED EFFICACY
WO2004024925A3 (en) Collectin-complement activating protein chimeras
WO2002089794A8 (en) Method for treating neuropathic pain and pharmaceutical preparation therefor
ES2114616T5 (en) INSULATED ALIFATIC DICARBOXILIC ACIDS.
WO2004073616A3 (en) Elastin digest compositions and methods utilizing same
ATE430165T1 (en) PEPTIDES WITH INTEGRIN BINDING MOTIVE AND TREATMENT METHODS FOR MUSCLE DISEASES
MXPA02012075A (en) Composition for pain mediation and apparatus and method of use thereof.
CA2322878A1 (en) Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
WO2003063775A3 (en) Methods and compositions for the promotion of hair growth utilizing actin binding peptides
AU2003292326A1 (en) Cosmetic or pharmaceutical composition comprising peptides with the sequence arg-gly-ser
WO2003007876A3 (en) N-fatty acid-amino acid conjugates and therapeutic uses
EP0967276A3 (en) Anti-tumor agent comprising salmosin
US20020028765A1 (en) Process for improving the growth of human head hair
JPH0778026B2 (en) Topical base for skin
EP1361905B8 (en) Matrix protein compositions for guided connective tissue growth
DE60239705D1 (en) THROMBIN-DERIVED PEPTIDES FOR PROMOTING HEART RANGE REPAIR
WO2002054996A3 (en) Terazosin transdermal device and methods
ES2168772T3 (en) USE OF HORMONE OF GROWTH IN COMPOSITIONS FOR THE TREATMENT OF HEART RESISTANCE TO INSULIN.
WO2004087091A3 (en) Cosmetic or pharmaceutical composition comprising amino acids, use and dermatological treatment methods
DE60134656D1 (en) ADDITIVES AND METHODS FOR THE TRANSDERMAL APPLICATION OF FELODIPIN
WO2004093832A3 (en) Cosmetic or pharmaceutical composition comprising a combination of at least one diacylglycerol and at least one fatty alcohol

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DE DK DK DM DZ EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2410965

Country of ref document: CA

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP